Skip to main content

Showing results for Alzheimer's disease

IU researchers pioneering noninvasive technique for neurological conditions

Indiana University School of Medicine researchers are developing a new, noninvasive brain stimulation technique to treat neurological disorders, including pain, traumatic brain injury (TBI), epilepsy, Parkinson’s disease, Alzheimer’s disease and more.

Christina Griffiths  |  Jul 01, 2021

IU School of Medicine receives $30 million NIA grant for Alzheimer's, related dementia research

National Centralized Repository for Alzheimer’s Disease and Related Dementias (NCRAD) grant has been renewed for another five years with funding expected to total $30 million from the National Institute on Aging (NIA), within the National Institutes of the Health (NIH). NCRAD is led by Tatiana Foroud, PhD, Executive Associate Dean for Research Affairs at IU School of Medicine. Since 2018, NCRAD has been among the five largest grants awarded to IU School of Medicine.

IU School of Medicine  |  Jun 29, 2021

IU School of Medicine researchers develop computer program to predict whether patients could be at high risk for Alzheimer’s and cancer

A group of researchers from Indiana University School of Medicine and Indiana University Bloomington have developed a program called Multi-Omics Graph cOnvolutional NETworks (MOGONET) that integrates omics data – such as DNA, RNA and proteins – to help researchers get a comprehensive understanding of human diseases. MOGONET can identify potential biomarkers for Alzheimer’s disease and cancers from the various omics data to predict which individuals may be at higher risk. 

IU School of Medicine  |  Jun 23, 2021

IU School of Medicine reaches NIH funding milestone, continues record-setting trend

INDIANAPOLIS—For the fifth-straight year, Indiana University School of Medicine set a school record for research funding received from the National Institutes of Health, showcasing its continued leadership in the field of medical research.

IU School of Medicine  |  Jan 27, 2021

IU researchers join nationwide effort to use artificial intelligence in study of Alzheimer's disease

A new $17.8 million grant will help researchers discover novel ways to prevent and treat Alzheimer’s disease through state-of-the-art artificial intelligence (AI) methods.

Christina Griffiths  |  Oct 15, 2020

IU School of Medicine, partners receive $1.3 million to deploy collaborative statewide dementia care model

Supported by a $1.3 million grant from the U.S. Administration for Community Living, Department of Health and Human Services, Indiana University School of Medicine and its partners have launched a 36-month venture to enhance, strengthen and expand supports for people with Alzheimer’s Disease and Related Dementias and their caregivers in 34 Indiana counties.

IU School of Medicine  |  Sep 14, 2020

Palkowitz named Indiana Biosciences Research Institute President and CEO

A veteran researcher and Indiana University School of Medicine faculty member will be taking on a new role with the Indiana Biosciences Research Institute—a leading industry-inspired applied research institute. Alan Palkowitz, PhD, was named the new president and CEO of the IBRI in an announcement on Wednesday, September 2. Palkowitz will spend 80 percent of his time at the IBRI serving in this new position, while maintaining his role at IU School of Medicine as a senior research professor of medicine and leader of the IUSM-Purdue TaRget Enablement to Accelerate Therapy Development for Alzheimer’s Disease (TREAT-AD) Center.

IU School of Medicine  |  Sep 02, 2020

IU School of Medicine continues record-setting research trend; up 5 spots in National Institutes of Health rankings

­INDIANAPOLIS – For the fourth-straight year, Indiana University School of Medicine set a school record for research funding received from the National Institutes of Health, demonstrating national leadership in critical fields like Alzheimer’s disease and pediatrics and providing a major boost to the Indiana economy. IU School of Medicine scientists and physicians were awarded over […]

IU School of Medicine  |  Jan 28, 2020

First randomized clinical trial found no harms from dementia screening in primary care

INDIANAPOLIS – Research scientists at Regenstrief Institute and Indiana University School of Medicine have conducted the first randomized controlled trial to evaluate the pros and cons of population screening for dementia. The researchers found no harm, as measured by patient reported depressive and anxiety symptoms, from screening for Alzheimer’s disease and related dementia in diverse […]

IU School of Medicine  |  Jan 15, 2020

IU School of Medicine awarded $36 million NIH grant for Alzheimer's disease drug discovery center

INDIANAPOLIS — Indiana University School of Medicine has been awarded a grant expected to total $36 million over five years from the National Institutes of Health to launch a drug discovery center to accelerate the development of promising treatments for Alzheimer’s disease. The center is a strategic partnership with the Purdue Institute for Drug Discovery. […]

IU School of Medicine  |  Oct 01, 2019